Clinical Trials
15 trialsNCT01758042 2026-03-06
BMT
Massachusetts General Hospital
Phase NA Completed
NCT03904134 2026-01-05
BMT CTN 1702
Center for International Blood and Marrow Transplant Research
Phase NA Completed
NCT03938324 2025-07-28
PiCASO
Duke University
Phase NA Completed
NCT05732922 2025-03-30
ORCHARD
University of Aberdeen
Phase NA Completed
NCT02895841 2024-05-23
Patient-Empowered Mobile Technology in Hospitalized Patients (TRU-PAIN)
Duke University
Phase NA Completed
NCT04574050 2024-03-19
SELF-BREATHE RCT for Chronic Breathlessness
King's College Hospital NHS Trust
Phase NA Completed
NCT03036813 2023-07-27
GBT_HOPE
Pfizer
Phase 3 Completed
NCT04629430 2023-01-04
HCTDiet
University of Virginia
Phase NA Completed
NCT04892160 2021-05-19
Distracting Through Procedural Pain and Distress
Medical College of Wisconsin
Phase NA Completed
NCT01179217 2020-08-19
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Emmaus Medical, Inc.
Phase 3 Completed
NCT01895361 2020-01-31
SUSTAIN
Reprixys Pharmaceutical Corporation
Phase 2 Completed
NCT01572922 2019-06-11
Massive Iron Deposit Assessment
St. Jude Children's Research Hospital
Phase NA Completed
NCT01049854 2018-08-21
CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
New York Medical College
Phase 2 Completed
NCT00236041 2014-05-09
Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Completed
NCT00236093 2014-05-09
Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Completed